ArticleMolecular biology reports2026
Expression and functional characterisation of the zinc-dependent metalloprotease LIC11568 from Leptospira interrogans reveals collagenolytic activity.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMetalloproteases are important virulence factors that facilitate bacterial dissemination through degradation of host extracellular matrix proteins. While proteolytic activities have been reported in pathogenic Leptospira, the biochemical characterisation of individual metalloproteases remains limited. METHODS AND
resultsIn this study, the putative M23 metalloprotease LIC11568 from Leptospira interrogans was characterised using bioinformatic analysis, recombinant protein production by cell-free protein synthesis, affinity purification, matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) peptide mass fingerprinting, and functional enzymatic assays. Bioinformatic analysis supported the previously reported LysM and M23 metallopeptidase domain architecture of LIC11568 and additionally predicted an N-terminal signal peptide. Recombinant LIC11568 was successfully produced using cell-free protein synthesis after recombinant protein production was not detectable by SDS-PAGE in Escherichia coli under the conditions tested, and its identity was supported by MALDI-TOF peptide mass fingerprinting. Functional assays demonstrated that LIC11568 degraded Type I collagen in a time-dependent manner, with maximum activity observed after 5 h at pH 8.0 and 37 °C. Collagenolytic activity increased with enzyme concentration and was strongly inhibited by 1,10-phenanthroline. Activity was restored by Zn²⁺, whereas Ca²⁺ alone failed to recover activity, supporting the zinc dependence of LIC11568 under the tested conditions.
conclusionThis study provides the first biochemical characterisation of LIC11568 as a functional M23 collagenolytic metalloprotease from L. interrogans. Its ability to degrade Type I collagen in vitro identifies collagen as a substrate under the conditions tested and provides a basis for further investigation of its substrate specificity and potential role in extracellular matrix interactions during leptospiral infection.
Indexed as
Identifiers
42848094What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.